Skip to content
Recruiting

Arterial Stiffness in Individuals With Breast Cancer

About this study

The aim of this study was to evaluate vascular toxicity induced by anthracyclines and other anticancer drugs and to measure arterial stiffness in women with breast cancer and, in addition, to evaluate the acute and chronic arterial stiffness responses of upper extremity aerobic exercise training.

Condition
Aerobic Exercise, Breast Cancer, Arterial Stiffness
Tested
Upper Extremity Aerobic Exercise Training Program
Sponsor
Hacettepe University

Who can join

Age
40 to 69 years
Sex
Female only
Healthy volunteers
Not accepted

Inclusion 12

  • Minimum age: 40 years
  • Maximum age: 69 years
  • Eligible sex: Female
  • Study condition: Aerobic Exercise, Breast Cancer, Arterial Stiffness
  • To be between the ages of 40-69,
  • Baseline left ventricular ejection fraction (LVEF) \>50%,
  • Absence of coronary artery disease and haemodynamically significant valvular heart disease,
  • Absence of carotid atherosclerotic plaques,
  • Volunteering to participate in the research,
  • At least 15 months after breast cancer surgery,
  • No problems in reading and/or understanding the scales and being able to co-operate with the tests.
  • Physically inactive (60 minutes of structured exercise per week \<).

Exclusion 7

  • Presence of active infection,
  • Presence of bilateral breast cancer,
  • History of surgical, neurological or orthopaedic problems that may affect upper extremity functionality other than breast cancer surgery,
  • Having a neurological disease or other clinical diagnosis that may affect cognitive status,
  • Left ventricular dysfunction and severe liver and kidney dysfunction before starting chemotherapy
  • Musculoskeletal and neurological disease that may affect exercise performance, symptomatic heart disease, previous lung surgery and malignant disease.
  • Presence of unstable hypertension or diabetes mellitus.

Where

1 site, 1 recruiting

Hacettepe University

Ankara, State, Turkey (Türkiye)

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.